Hematopoietic Stem Cell Therapy for Wiskott–Aldrich Syndrome: Improved Outcome and Quality of Life

Hematopoietic Stem Cell Therapy for Wiskott–Aldrich Syndrome: Improved Outcome and Quality of Life

Kanwaldeep K Mallhi,1– 3 Aleksandra Petrovic,1,2,4,* Hans D Ochs2,5,* 1Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 2Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; 3Division of Hematology and Oncology, Seattle Children’s Hosp...

Full description

Bibliographic Details
Main Authors: Mallhi KK, Petrovic A, Ochs HD
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:Journal of Blood Medicine
Subjects:
wiskott-aldrich syndrome (was)
x-linked thrombocytopenia (xlt)
x-linked neutropenia (xln)
hematopoietic stem cell transplantation (hsct)
reduced intensity conditioning
gene therapy (gt)
lentiviral vectors
Online Access:https://www.dovepress.com/hematopoietic-stem-cell-therapy-for-wiskottaldrich-syndrome-improved-o-peer-reviewed-fulltext-article-JBM

Internet

https://www.dovepress.com/hematopoietic-stem-cell-therapy-for-wiskottaldrich-syndrome-improved-o-peer-reviewed-fulltext-article-JBM

Similar Items